GH Research GHRS
NASDAQ GHRS
$28.23 +0.31 (+1.11%)
As of: Sep 4, 2026 · 3:59 PM EDT

GH Research (GHRS) Cash from Operations (2020 - 2026)

GH Research (GHRS) posted quarterly Cash from Operations of 12330000.0 for Q4 2025, down 18.04% year-over-year from 15043118.43 in Q4 2024, and up 9.88% quarter-over-quarter from 13682000.0 in Q3 2025.

Analysis

GH Research (GHRS) Cash from Operations (2020 - 2026) Analysis & Trends

GH Research's Cash from Operations history runs 6 years deep, the most recent figure standing at 12330000.0 for Q4 2025.

  • In Q4 2025, Cash from Operations fell 18.04% year-over-year to 12330000.0; the TTM figure through Dec 2025 stood at 43552000.0 (down 3.0% YoY), while the FY2025 annual figure was 43552000.0, down 3.0% from the prior year.
  • Cash from Operations for Q4 2025 stood at 12330000.0, up from 13682000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 1087000.0 in Q1 2021, with the low at 13682000.0 in Q3 2025.
  • The 5-year median for Cash from Operations is 8770000.0 (2025), against an average of 8238400.0.
  • The sharpest annual moves came in 2021 and 2022: Cash from Operations sank 11864.94% in 2021, then advanced 12.68% in 2022.
  • GH Research's Cash from Operations stood at 3758000.0 in 2021, then sank by 95.45% to 7345000.0 in 2022, then plunged by 59.56% to 11720000.0 in 2023, then rose by 10.87% to 10446000.0 in 2024, then fell by 18.04% to 12330000.0 in 2025.
  • Business Quant data shows GHRS's Cash from Operations at 12330000.0 in Q4 2025, 13682000.0 in Q3 2025, and 8967000.0 in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.13 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 813.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -526.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -387.32 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 462.82 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 326.72 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 728.46 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -88.83 Mn
10 GH Research 1.72 Bn 1.36 Bn - -15.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -15.02 Mn
Mar 31, 2026 -10.67 Mn
Dec 31, 2025 -12.33 Mn
Sep 30, 2025 -13.68 Mn
Jun 30, 2025 -8.97 Mn
Mar 31, 2025 -8.57 Mn
Dec 31, 2024 -10.45 Mn
Sep 30, 2024 -12.31 Mn
Jun 30, 2024 -9.94 Mn
Mar 31, 2024 -9.60 Mn
Dec 31, 2023 -8.09 Mn
Sep 30, 2023 -10.34 Mn
Jun 30, 2023 -8.03 Mn
Mar 31, 2023 -6.89 Mn
Dec 31, 2022 -6.87 Mn
Sep 30, 2022 -8.05 Mn
Jun 30, 2022 -5.29 Mn
Mar 31, 2022 -6.00 Mn
Dec 31, 2021 -3.76 Mn
Sep 30, 2021 -9.21 Mn